Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
9
×
boston blog main
indiana blog main
indiana top stories
national blog main
raleigh-durham blog main
raleigh-durham top stories
archive
biotech
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
life sciences
medicine
national
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
bristol-myers squibb
eli lilly
medical
abeona therapeutics
affordable care act
agios pharmaceuticals
alirocuma
alzheimer's
ameet nathwani
amgen
What
pharmaceutical
9
×
bio
roundup
based
drug
drugs
fda
american
appetite
best
brand
company
continue
crash
debate
eli
giant
healthcare
help
industry
kind
medication
migraine
nash
new
people
policy
politicians
pressure
recalled
risk
scalps
trump’s
u.s
accor
acute
addresses
administration
adults
anticipated
Language
unset
Current search:
pharmaceutical
×
fda
×
@slashgear.com
2 years ago
Merck’s COVID-19 pill isn’t quite as effective as initially reported
@slashgear.com
2 years ago
FDA says lidocaine numbing product recalled because it’s too potent
@slashgear.com
2 years ago
FDA approves powerful appetite suppressant for obese adults
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades
@slashgear.com
4 years ago
Popular migraine drug recalled over potentially serious bacteria risk
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More